Advertisement

CDC: Consider Chikungunya Infection in Recent Caribbean Travelers — Physician’s First Watch

Medical News |
December 16, 2013

CDC: Consider Chikungunya Infection in Recent Caribbean Travelers

By Amy Orciari Herman

Infection with chikungunya, a mosquito-borne virus, should be considered in patients with acute-onset fever and polyarthralgia who've recently traveled to the Caribbean, the CDC said on Friday. Ten cases have been confirmed in people who reside on the French side of St. Martin in the past 2 months. It's the first time the virus has been transmitted locally in the Americas.

Currently, there are no drugs or vaccines to prevent this infection, nor are there any specific antiviral agents to treat it.

The CDC provides information on clinical presentation, diagnosis, management, and reporting to public health authorities at the link below.

Reader Comments (2)

Elena *Benazzi Physician, Hematology, Transplant coordinator

Is raising the concern about the risk of trasmission from organ donors?

Birge D O Physician, Preventive Medicine, NYC

Leadership, meticulous planning, gearing up and going on the offensive can likely stem this dangerous virus from invading.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement